Home / Inspections / 1311680

FDA Inspection 1311680 — Mylan Pharmaceuticals Inc

Mylan Pharmaceuticals Inc — FEI 1110315

The FDA completed an inspection of Mylan Pharmaceuticals Inc on April 28, 2026 in Morgantown, WV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 28, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morgantown, WV (United States)

Facility

Other inspections at this facility

  • 1219018 (NAI Fri Aug 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1170444 (VAI Thu May 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099590 (VAI Thu Aug 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1076082 (NAI Fri Nov 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1072148 (NAI Wed Nov 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources